Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.55 - $1.47 $16,665 - $44,541
-30,300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.29 - $2.36 $6,966 - $12,744
5,400 Added 21.69%
30,300 $40,000
Q3 2021

Nov 12, 2021

BUY
$1.81 - $2.7 $2,353 - $3,510
1,300 Added 5.51%
24,900 $53,000
Q2 2021

Aug 06, 2021

BUY
$2.07 - $2.89 $11,592 - $16,184
5,600 Added 31.11%
23,600 $64,000
Q1 2021

May 14, 2021

SELL
$2.34 - $3.44 $27,144 - $39,904
-11,600 Reduced 39.19%
18,000 $44,000
Q4 2020

Feb 12, 2021

BUY
$1.91 - $5.63 $56,536 - $166,648
29,600 New
29,600 $84,000

Others Institutions Holding SIOX

About Sio Gene Therapies Inc.


  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.